BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11554171)

  • 1. Waldenström macroglobulinemia. Development of diagnostic criteria and identification of prognostic factors.
    Owen RG; Barrans SL; Richards SJ; O'Connor SJ; Child JA; Parapia LA; Morgan GJ; Jack AS
    Am J Clin Pathol; 2001 Sep; 116(3):420-8. PubMed ID: 11554171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
    Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
    Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing diagnostic criteria in Waldenstrom's macroglobulinemia.
    Owen RG
    Semin Oncol; 2003 Apr; 30(2):196-200. PubMed ID: 12720135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
    Konoplev S; Medeiros LJ; Bueso-Ramos CE; Jorgensen JL; Lin P
    Am J Clin Pathol; 2005 Sep; 124(3):414-20. PubMed ID: 16191510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
    Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
    Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
    Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
    Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
    San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
    Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoplasmacytic lymphoma-Waldenstrom's macroglobulinemia.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Aug; 67(2):172-85. PubMed ID: 18499469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic model for disease-specific and overall mortality in newly diagnosed symptomatic patients with Waldenstrom macroglobulinaemia.
    Ghobrial IM; Fonseca R; Gertz MA; Plevak MF; Larson DR; Therneau TM; Wolf RC; Hoffmann RJ; Lust JA; Witzig TE; Lacy MQ; Dispenzieri A; Vincent Rajkumar S; Zeldenrust SR; Greipp PR; Kyle RA
    Br J Haematol; 2006 Apr; 133(2):158-64. PubMed ID: 16611306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA; Lorie IuIu; Melikian AL; Samoĭlova RS; Bulycheva TI; Obukhova TN; Kaplanskaia IB; Doronin VA; Kolosova LIu; Goriacheva SR
    Ter Arkh; 2003; 75(7):38-47. PubMed ID: 12934480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.
    Cesana C; Miqueleiz S; Bernuzzi P; Tresoldi E; Rossi V; D'avanzo G; Filippini D; Morra E
    Semin Oncol; 2003 Apr; 30(2):231-5. PubMed ID: 12720142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
    Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
    Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.
    Naderi N; Yang DT
    Arch Pathol Lab Med; 2013 Apr; 137(4):580-5. PubMed ID: 23544948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: a two-institution study.
    Björkholm M; Johansson E; Papamichael D; Celsing F; Matthews J; Lister TA; Rohatiner AZ
    Semin Oncol; 2003 Apr; 30(2):226-30. PubMed ID: 12720141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.